GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MedSci Healthcare Holdings Ltd (HKSE:02415) » Definitions » Net Income

MedSci Healthcare Holdings (HKSE:02415) Net Income : HK$60.2 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is MedSci Healthcare Holdings Net Income?

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. MedSci Healthcare Holdings's Net Income for the six months ended in Dec. 2023 was HK$47.2 Mil. Its Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was HK$60.2 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. MedSci Healthcare Holdings's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was HK$0.09.


MedSci Healthcare Holdings Net Income Historical Data

The historical data trend for MedSci Healthcare Holdings's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedSci Healthcare Holdings Net Income Chart

MedSci Healthcare Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Net Income
34.28 -184.93 -111.54 60.20

MedSci Healthcare Holdings Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Net Income Get a 7-Day Free Trial - -125.66 8.17 13.04 47.17

MedSci Healthcare Holdings Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

MedSci Healthcare Holdings's Net Income for the fiscal year that ended in Dec. 2023 is calculated as

Net Income(A: Dec. 2023 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=66.119+-5.915+0+0
=60.2

MedSci Healthcare Holdings's Net Income for the quarter that ended in Dec. 2023 is calculated as

Net Income(Q: Dec. 2023 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=52.022+-4.856+0+0
=47.2

Net Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$60.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedSci Healthcare Holdings  (HKSE:02415) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

MedSci Healthcare Holdings's Earnings per Share (Diluted) (EPS) for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


MedSci Healthcare Holdings Net Income Related Terms

Thank you for viewing the detailed overview of MedSci Healthcare Holdings's Net Income provided by GuruFocus.com. Please click on the following links to see related term pages.


MedSci Healthcare Holdings (HKSE:02415) Business Description

Traded in Other Exchanges
N/A
Address
No. 258, Xinzhuan Road, 18th Floor, Building 34, Songjiang District, Shanghai, CHN
MedSci Healthcare Holdings Ltd is an investment holding company. It operates online professional physician platforms in China. The principal activities of the Company are the provision of physician platform solutions, precision omni-channel marketing solutions, and real-world study solutions in the People's Republic of China.
Executives
Li Xinmei 2202 Interest of your spouse
Zhang Fabao 2201 Interest of corporation controlled by you
Dtx Health Limited 2101 Beneficial owner
Yu Jia 2201 Interest of corporation controlled by you
Dragon Step Ventures Limited 2101 Beneficial owner
Shanghai Qichang Investment Consulting Co., Ltd. 2201 Interest of corporation controlled by you
Suzhou Qicheng Investment Management Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Suzhou Qiming Ronghe Venture Capital Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Image Frame Investment (hk) Limited
Tencent Holdings Limited
Microhealth Limited 2101 Beneficial owner
Hu Xubo 2201 Interest of corporation controlled by you
Meiyue Limited 2101 Beneficial owner

MedSci Healthcare Holdings (HKSE:02415) Headlines

No Headlines